Eszopiclone-containing particle and its preparation method

A technology for eszopiclone and granules, which is applied in the field of eszopiclone-containing granules and their preparation, can solve the problems of gastrointestinal adverse reactions, complicated composition and preparation methods, and restrictions on the development of eszopiclone oral preparations, etc. The advantages of drug application: no bad smell, avoid gastrointestinal adverse reactions, and overcome the effect of difficult preparation process

Active Publication Date: 2012-10-17
CHENGDU KANGHONG PHARMA GRP
View PDF7 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, eszopiclone can produce extremely strong and persistent bitter taste in the oral cavity, and this shortcoming makes the development of oral formulations of eszopiclone greatly limited
Although the common tablets of eszopiclone currently on the market provide a choice for the application of eszopiclone, the disadvantages and limitations of use of conventional common tablets are also very obvious: 1. It cannot effectively cover the bad taste of the drug, causing disintegration The disintegration and drug dissolution time is longer, and the curative effect is slow; although the film-coated tablet has a taste-masking effect to a certain extent, its disintegration and drug dissolution may be worse; 2. The local concentration of the drug after disintegration is high, which may easily cause gastric Intestinal adverse reactions; 3. It must be swallowed whole, and the elderly, children and other patients with dysphagia have poor compliance; 4. The swallowed tablets may stick to the esophagus, causing foreign body sensation or even drug-induced esophageal damage
In conclusion, ordinary tablets are difficult to maximize the application advantages of eszopiclone
CN1418631A discloses a zopiclone orally disintegrating tablet. Although the tablet is dissolved in the oral cavity and is easy to swallow, the disintegrating tablet cannot effectively cover the bitter taste of zopiclone, and patients have a certain sense of rejection
We have found through experiments that this method has the following defects when it is used to prepare eszopiclone granules: 1. Due to the difference in bulk density between eszopiclone bulk drug and excipient powder, it is easy to stratify in a fluidized state, resulting in poor particle content uniformity; 2. The powder of eszopiclone raw material medicine is easy to fly and adhere to the fluidized bed equipment during the fluidization process, resulting in a large loss
We fo

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Eszopiclone-containing particle and its preparation method
  • Eszopiclone-containing particle and its preparation method
  • Eszopiclone-containing particle and its preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1 to 3

[0098] Embodiment formula and evaluation result are shown in Table 10, Table 11, Table 12.

[0099] Preparation method: Dissolve the adhesive in water, add eszopiclone powder (through a 200-mesh sieve), and disperse for 15 minutes under high shear (IKAT25 high-shear disperser, 1000 rpm) to make a suspension; take the blank The pellet core is placed in a fluidized bed, heated by fluidization, and the suspension containing eszopiclone is sprayed on the blank pellet core by the bottom spray method, and the fluidized drying is continued to obtain the drug-loaded core particle; the surfactant and / or Disperse the plasticizer with water, slowly add the film-forming material under stirring to obtain a water dispersion, take the anti-sticking agent and add it to the water for high-shear dispersion for 15 minutes (IKA T25 high-shear disperser, 1000 rpm), and then add it to the aforementioned water dispersion The coating solution is obtained in the body; the above-mentioned drug-loaded c...

Embodiment 4 to 6

[0109] Embodiment formula and evaluation result are shown in Table 13, Table 14, Table 15.

[0110] Preparation method: Dissolve the binder in water, add eszopiclone powder (passed through a 200-mesh sieve), and disperse for 15 minutes under high shear (IKA T25 high-shear disperser, 1000 rpm) to make a suspension; The blank core is placed in a fluidized bed, heated by fluidization, and the suspension containing eszopiclone is sprayed onto the blank core by the bottom spray method, and the fluidized drying is continued to obtain drug-loaded core particles; film-forming materials, plasticizers Agent, anti-sticking agent are dispersed with ethanol, high-shear dispersion 15 minutes (IKA T25 high-shear disperser, 1000 revs / min), obtain taste-masking coating liquid; Taste-masked granules are obtained by coating.

[0111] Table 13 Example 4 to 6 Eszopiclone core granule formula (by weight ratio)

[0112]

[0113] Table 14 embodiment 4 to 6 coating solution formula (by weight rat...

Embodiment 7

[0118] Example 7 (preparation of orally disintegrating tablets using eszopiclone taste-masking granules)

[0119] Take the eszopiclone taste-masking granules prepared in Example 5, mix them evenly with the excipients except magnesium stearate according to the formula in Table 16, then add magnesium stearate and mix for 5 minutes, and press into tablets to adjust the tablet weight to about 200 mg.

[0120] Table 16 Eszopiclone taste-masked orally disintegrating tablet and its evaluation results (by weight ratio)

[0121] Material name

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention relates to an eszopiclone-containing particle and its preparation method. The particle can cover the bitter taste of eszopiclone, has no obvious sandy feeling, has uniform contents and high dissolution rate, and can be used for preparing solid dosage forms such as orally disintegrating tablets, dispersing tablets, suspension granules and the like.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to eszopiclone-containing granules and a preparation method thereof. Background technique [0002] Insomnia is a manifestation of sleep disorders. Insomnia not only causes changes in perception and spirit, but also may cause functional diseases and even induce other diseases, which is a great potential threat to human health. At present, nearly 1 / 4 of the people in the world suffer from insomnia, and more than 10% of people in our country have sleep disorders. When insomnia is severe and sleep hygiene and nonpharmacologic treatments are ineffective, drug therapy is the first choice. [0003] Commonly used sedative and hypnotic drugs such as barbiturates and benzodiazepines often have various side effects, such as causing drowsiness, fatigue, dizziness, ataxia, temporary amnesia and disturbance of consciousness. In severe cases, it may lead to coma and respiratory depress...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/20A61K9/16A61K31/4985A61K47/32A61K47/34A61K47/36A61K47/38A61K47/42A61P25/20
Inventor 王万柯尊洪郑强
Owner CHENGDU KANGHONG PHARMA GRP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products